FEROZ reported a strong revenue growth of Rs 6.68 billion, with a profit after taxation of Rs 344.45 million
Filed as: Financial Results for the Quarter Ended 31-12-2025
Summary
FEROZ reported a strong revenue growth of Rs 6.68 billion, with a profit after taxation of Rs 344.45 million.
Read the original filingFigures in the filing
| Item | This period | Period before | Change |
|---|---|---|---|
| Revenue | 6682.57 | 4730.95 | +41.3% |
| Gross Profit | 3050.4 | 2089.72 | +46.0% |
| Profit After Taxation | 344.45 | 177.55 | +94.0% |
| Total Assets | 26.76 | 24.61 | +8.7% |
| Total Equity | 14.96 | 14.47 | +3.4% |
Amounts are in Pakistani rupees as stated in the filing (M = million, B = billion).
What the filing says
- Revenue rose to Rs 6.68 billion from Rs 4.73 billion, up 41.2%
- Gross profit increased to Rs 3.05 billion from Rs 2.09 billion, reflecting improved operational efficiency.
- Profit after taxation surged to Rs 344.45 million from Rs 177.55 million, indicating strong profitability.
Ferozsons Laboratories Limited (FEROZ) on Nafa
Last price Rs 364.02 · Pharmaceuticals · You can own FEROZ shares from your phone.
More FEROZ announcements
- NoticeCredit of final cash dividend
- NoticeChange of Company Secretary
- NoticeCompany Secretary
- NoticeTransmission of Quarterly Financial Statements for the Period Ended 30-09-2026
- Financial resultFerozsons Laboratories Limited reported a strong performance for the first quarter ended 30 September 2026Filed as: Financial Results for the Quarter Ended 30-09-2026
- NoticeCertified True Copies of the Resolutions passed at the 70th Annual General Meeting of the Company
Source: Ferozsons Laboratories Limited's filing with the Pakistan Stock Exchange. The summary and figures on this page are extracted from the filing by software and can contain errors; the filing itself is the record. This page describes the filing. It is not investment advice and Nafa does not recommend any stock. Investing in securities involves risk, including possible loss of principal.